-
Adial Pharma Selects Crown CRO for Phase III Trial
contractpharma
November 28, 2018
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, has selected Crown CRO, based in Finland, to manage its Phase III trial for AD04 for the treatment of alcohol use disorder (AUD).
-
Novotech, CNS to expand CRO services to biopharma across APAC
biospectrumasia
November 23, 2018
As part of the deal, clients can access leading services from both groups including the CNS BioDesk, that provides early stage product development advice including toxicology,
-
Schrödinger, WuXi launch virtual drug discovery JV
fiercebiotech
November 02, 2018
WuXi AppTec and Schrödinger unveiled Faxian Therapeutics, a joint venture aimed at accelerating drug discovery. The new company will use Schrödinger’s computational drug
-
AstraZeneca boosts drug discovery through partnership
biospectrumasia
October 29, 2018
AstraZeneca boosts drug discovery through partnership
-
CRO Survey 2014: CRO Landscape across APAC
biospectrumasia
October 24, 2018
CRO Survey 2014: CRO Landscape across APAC
-
Quintiles bags Frost and Sullivan's 'APAC CRO of the Year' award
biospectrumasia
October 23, 2018
Quintiles bags Frost and Sullivan's 'APAC CRO of the Year' award
-
GVK BIO eyes top spot among Asian CROs
biospectrumasia
October 23, 2018
With its new brand, the company will strengthen its operational expertise technology to evolve into a specialist and co
-
Crystal Pharmatech, Partner Sciences join hands
biospectrumasia
October 23, 2018
China's Crystal Pharmatech partners with US Partner Sciences
-
Covance recieves Frost and Sullivan Award
biospectrumasia
October 23, 2018
Covance has recieved 2014 Frost Sullivan Asia Pacific CRO Growth Excellence Leadership AwardSingapore:Covance, a global
-
Changes in Chinese regulations stimulate market for CRO
biospectrumasia
September 13, 2018
This announcement is especially beneficial for Contract Research Organizations (CROs) like Accutest which have an early mover advantage in the Chinese market.